Giuseppe
Emeritus
[Source: Eurosurveillance, full text: (LINK). Abstract, edited.]
Eurosurveillance, Volume 16, Issue 37, 15 September 2011
Surveillance and outbreak reports
Chagas disease in Italy: breaking an epidemiological silence
A Angheben (
)<SUP>1</SUP><SUP>,2</SUP>, M Anselmi<SUP>1</SUP><SUP>,2</SUP>, F Gobbi<SUP>1</SUP><SUP>,2</SUP>, S Marocco<SUP>1</SUP>, G Monteiro<SUP>1</SUP>, D Buonfrate<SUP>1</SUP><SUP>,2</SUP>, S Tais<SUP>3</SUP>, M Talamo<SUP>4</SUP>, G Zavarise<SUP>5</SUP>, M Strohmeyer<SUP>6</SUP><SUP>,2</SUP>, F Bartalesi<SUP>6</SUP>, A Mantella<SUP>6</SUP>, M Di Tommaso<SUP>7</SUP>, K H Aiello<SUP>7</SUP>, G Veneruso<SUP>8</SUP>, G Graziani<SUP>9</SUP>, M M Ferrari<SUP>10</SUP>, I Spreafico<SUP>10</SUP>, E Bonifacio<SUP>11</SUP>, G Gaiera<SUP>12</SUP>, M Lanzafame<SUP>13</SUP>, M Mascarello<SUP>13</SUP>, G Cancrini<SUP>14</SUP>, P Albajar-Vi?as<SUP>15</SUP>, Z Bisoffi<SUP>1</SUP><SUP>,2</SUP>, A Bartoloni<SUP>6</SUP><SUP>,2</SUP>
Citation style for this article: Angheben A, Anselmi M, Gobbi F, Marocco S, Monteiro G, Buonfrate D, Tais S, Talamo M, Zavarise G, Strohmeyer M, Bartalesi F, Mantella A, Di Tommaso M, Aiello KH, Veneruso G, Graziani G, Ferrari MM, Spreafico I, Bonifacio E, Gaiera G, Lanzafame M, Mascarello M, Cancrini G, Albajar-Vi?as P, Bisoffi Z, Bartoloni A. Chagas disease in Italy: breaking an epidemiological silence. Euro Surveill. 2011;16(37)
ii=19969. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19969
Date of submission: 12 March 2011 <HR>Chagas disease, a neglected tropical disease that due to population movements is no longer limited to Latin America, threatens a wide spectrum of people (travellers, migrants, blood or organ recipients, newborns, adoptees) also in non-endemic countries where it is generally underdiagnosed. In Italy, the available epidemiological data about Chagas disease have been very limited up to now, although the country is second in Europe only to Spain in the number of residents from Latin American. Among 867 at-risk subjects screened between 1998 and 2010, the Centre for Tropical Diseases in Negrar (Verona) and the Infectious and Tropical Diseases Unit, University of Florence found 4.2% patients with positive serology for Chagas disease (83.4% of them migrants, 13.8% adoptees). No cases of Chagas disease were identified in blood donors or HIV-positive patients of Latin American origin. Among 214 Latin American pregnant women, three were infected (resulting in abortion in one case). In 2005 a case of acute Chagas disease was recorded in an Italian traveller. Based on our observations, we believe that a wider assessment of the epidemiological situation is urgently required in our country and public health measures preventing transmission and improving access to diagnosis and treatment should be implemented.
- -------
Eurosurveillance, Volume 16, Issue 37, 15 September 2011
Surveillance and outbreak reports
Chagas disease in Italy: breaking an epidemiological silence
A Angheben (
- Centre for Tropical Diseases, Sacro Cuore ? Don Calabria Hospital, Negrar, Italy
- COHEMI project (COordinating resources to assess and improve HEalth status of MIgrants from Latin America)
- Service of Epidemiology and Laboratory for Tropical Diseases, Sacro Cuore ? Don Calabria Hospital, Negrar, Italy
- Infectious Disease Unit, G. Rummo Hospital, Benevento, Italy
- Paediatric Division, Sacro Cuore ? Don Calabria Hospital, Negrar, Italy
- Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy
- Obstetric and Gynaecologic Department, Careggi University Hospital, Florence, Italy
- Infectious Diseases Unit, Anna Meyer Children?s University Hospital, Florence, Italy
- Immunohaematology and Transfusion Unit, Careggi University Hospital, Florence, Italy
- Obstetrics and Gynaecology Clinic, L. Mangiagalli Hospital, Milan, Italy
- Obstetrics and Gynaecology Division, Sacro Cuore ? Don Calabria Hospital, Negrar, Italy
- Infectious Diseases Division, San Raffaele Hospital, Milan, Italy
- Infectious Diseases Division, G.B. Rossi University Hospital, Verona, Italy
- Public Health Sciences Department, La Sapienza University, Rome, Italy
- WHO Programme on Control of Chagas disease, Department of Control of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland
Citation style for this article: Angheben A, Anselmi M, Gobbi F, Marocco S, Monteiro G, Buonfrate D, Tais S, Talamo M, Zavarise G, Strohmeyer M, Bartalesi F, Mantella A, Di Tommaso M, Aiello KH, Veneruso G, Graziani G, Ferrari MM, Spreafico I, Bonifacio E, Gaiera G, Lanzafame M, Mascarello M, Cancrini G, Albajar-Vi?as P, Bisoffi Z, Bartoloni A. Chagas disease in Italy: breaking an epidemiological silence. Euro Surveill. 2011;16(37)
ii=19969. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19969 Date of submission: 12 March 2011 <HR>Chagas disease, a neglected tropical disease that due to population movements is no longer limited to Latin America, threatens a wide spectrum of people (travellers, migrants, blood or organ recipients, newborns, adoptees) also in non-endemic countries where it is generally underdiagnosed. In Italy, the available epidemiological data about Chagas disease have been very limited up to now, although the country is second in Europe only to Spain in the number of residents from Latin American. Among 867 at-risk subjects screened between 1998 and 2010, the Centre for Tropical Diseases in Negrar (Verona) and the Infectious and Tropical Diseases Unit, University of Florence found 4.2% patients with positive serology for Chagas disease (83.4% of them migrants, 13.8% adoptees). No cases of Chagas disease were identified in blood donors or HIV-positive patients of Latin American origin. Among 214 Latin American pregnant women, three were infected (resulting in abortion in one case). In 2005 a case of acute Chagas disease was recorded in an Italian traveller. Based on our observations, we believe that a wider assessment of the epidemiological situation is urgently required in our country and public health measures preventing transmission and improving access to diagnosis and treatment should be implemented.